BioStem Technologies (BioStem Technologies) EV-to-EBITDA : -25.56 (As of May. 21, 2024)

View and export this data going back to 2008. Start your Free Trial

What is BioStem Technologies EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, BioStem Technologies's enterprise value is $112.55 Mil. BioStem Technologies's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was $-4.40 Mil. Therefore, BioStem Technologies's EV-to-EBITDA for today is -25.56.

The historical rank and industry rank for BioStem Technologies's EV-to-EBITDA or its related term are showing as below:

BSEM' s EV-to-EBITDA Range Over the Past 10 Years
Min: -47.26 Med: -9.28 Max: -1.29
Current: -25.56

During the past 13 years, the highest EV-to-EBITDA of BioStem Technologies was -1.29. The lowest was -47.26. And the median was -9.28.

BSEM's EV-to-EBITDA is ranked worse than
100% of 458 companies
in the Biotechnology industry
Industry Median: 10.31 vs BSEM: -25.56

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-21), BioStem Technologies's stock price is $8.08. BioStem Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.410. Therefore, BioStem Technologies's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

BioStem Technologies EV-to-EBITDA Historical Data

The historical data trend for BioStem Technologies's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioStem Technologies EV-to-EBITDA Chart

BioStem Technologies Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EV-to-EBITDA

Get a 7-Day Free Trial

-4.11

-5.30

-11.97

-27.92

-6.37

BioStem Technologies Quarterly Data
	Sep15	Dec15	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Dec21	Mar22	Sep22	Dec22	Mar23	Sep23
EV-to-EBITDA	Get a 7-Day Free Trial															-6.69	-14.05	-6.37	-8.20	-9.12

Competitive Comparison of BioStem Technologies's EV-to-EBITDA

For the Biotechnology subindustry, BioStem Technologies's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioStem Technologies's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioStem Technologies's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where BioStem Technologies's EV-to-EBITDA falls into.

BioStem Technologies EV-to-EBITDA Calculation

BioStem Technologies's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	112.549	/	-4.404
	=	-25.56

BioStem Technologies's current Enterprise Value is $112.55 Mil.
BioStem Technologies's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.40 Mil.

BioStem Technologies (OTCPK:BSEM) EV-to-EBITDA Explanation

BioStem Technologies's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	8.08	/	-0.410
	=	At Loss

BioStem Technologies's share price for today is $8.08.
BioStem Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.410.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

BioStem Technologies EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of BioStem Technologies's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

BioStem Technologies (BioStem Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioStem Technologies Inc (OTCPK:BSEM) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

2836 Center Port Circle, Pompano Beach, FL, USA, 33064

Website

https://www.biostemtechnologies.com

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its proprietary approach, Local MicroEnvironment Activation, uses combinations of Small Molecules, Cytokines, and Growth Factors to activate the microenvironment within the body to create communication for repair in the tissue. The Company offers a comprehensive portfolio of high-quality brands that are trademarked and include RHEO, AEON, OROPRO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC.